By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) Presents Final Phase 1b Safety, Efficacy And Biomarker Data For Tarextumab In Pancreatic Cancer At The 2015 Gastrointestinal Cancer Symposium 1/19/2015 7:06:38 AM
OncoMed Pharmaceuticals, Inc. (OMED) Enrolls First Biomarker-Selected Patient In Expansion Stage Of Anti-Notch1 Phase 1a Trial In Solid Tumors 1/15/2015 7:06:09 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical Data And Biomarker Analysis For Tarextumab At The 2015 Gastrointestinal Cancer Symposium 1/13/2015 7:01:13 AM
OncoMed Pharmaceuticals, Inc. (OMED) Pre-Announces 2014 Year-End Cash Balance And Provides 2015 Guidance 1/12/2015 7:27:11 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:12:07 AM
OncoMed Pharmaceuticals, Inc. (OMED) Doses First Patient In Phase 1 Clinical Trial Of Novel Anti-DLL4/VEGF Bispecific Antibody 1/5/2015 7:08:52 AM
OncoMed Pharmaceuticals, Inc. (OMED) Begins Patient Dosing In Phase 2 Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) in Small Cell Lung Cancer 12/1/2014 9:46:30 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Piper Jaffray Healthcare Conference 11/21/2014 10:01:04 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
12345678910...
//-->